A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.

Key outcomes of all-cause mortality and portal hypertension complications are improved with SGLT2inhibitors, new research ...

The Laval Rocket returned to a packed Place Bell looking to apply the broom to the Cleveland Monsters in the North Division ...

Since its historic FDA approval in March 2024 as the first medication for the treatment of the prevalent liver disease ...

The Tigers (22-13) took three of four from the Angels and head into Monday’s off-day with the AL's best record.

I messed around and found out how these DIY food dish mash-up taste at New Orleans Jazz Fest. Here's the best of the bunch ...

Miní, a wild-born female jaguar, takes an unbelievable journey from the Iberá Wetlands to the Gran Chaco forest to revive a ...

How a commonly “silent disease” is driving urgency and novelty in the liver disease treatment paradigm and what can we hope for.

Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

New research shows a drug candidate's potential to combat liver disease and atherosclerosis effectively in nonhuman primates.